IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Triple combinations of neuraminidase inhibitors, statins and fibrates benefit the survival of patients with lethal avian influenza pandemic
An, Shu-Chang1; Xu, Li-Li2,3,4; Li, Feng-Di2,3,4; Bao, Lin-Lin2,3,4; Qin, Chuan2,3,4; Gao, Zhan-Cheng1
刊名MEDICAL HYPOTHESES
2011-12-01
DOI10.1016/j.mehy.2011.09.001
77期:6页:1054-1057
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, Research & Experimental
资助者Ministry of Science and Technology of China ; Ministry of Science and Technology of China
研究领域[WOS]Research & Experimental Medicine
关键词[WOS]A H5N1 INFECTION ; TRANSCRIPTION FACTORS ; VIRUS-INFECTION ; INFLAMMATION ; CELLS ; HMG-1 ; LIPOPOLYSACCHARIDE ; FENOFIBRATE ; EXPRESSION ; RESISTANCE
英文摘要

The high mortality of highly pathogenic avian influenza A (H5N1) viruses infection in humans gives rise to considerable concern that it might someday cause another lethal pandemic. At present there is no other effective alternative besides the early and enough administration of neuraminidase inhibitors, which may be crucial for the patient management. However, its efficacy is sometimes limited because of the late administration in some patients especially the seriously ill ones and the continual occurrence of oseltamivir resistant A (H5N1) strains. The specific candidate vaccine are still under development and the practical value of passive immunization is hard to be widely applied because of the scarcity of convalescent human plasma, especially in the early stage of a serious and rapidly progressing pandemic. Statins and fibrates, both of which are used in clinical practice, have anti-inflammatory and immunomodulatory effects and other multiple biologic activities. So we hypothesized that the two immunomodulatory agents may exhibit synergistic effects when they were combined to neuraminidase inhibitors to treat the A (H5N1) viruses infections via inhibiting the production of either the early inflammatory mediators (e.g., many cytokine/chemokine) or the late mediator (e.g., High Mobility Group Box Protein 1), even showing the anti-viral activities with the prevention of the development of antiviral resistance. Therefore, the novel triple combinations may be an optimal management to confront the next lethal influenza pandemic on its very beginning. (C) 2011 Elsevier Ltd. All rights reserved.

语种英语
所属项目编号2009ZX10004-016
资助者Ministry of Science and Technology of China ; Ministry of Science and Technology of China
WOS记录号WOS:000297400600031
Citation statistics
Cited Times:9[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/60708
Collection北京大学第二临床医学院
作者单位1.Peking Univ, Peoples Hosp, Dept Resp & Crit Care Med, Beijing 100044, Peoples R China
2.Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100021, Peoples R China
3.PUMC, Comparat Med Ctr, Beijing 100021, Peoples R China
4.Minist Hlth, Key Lab Human Dis Comparat Med, Beijing 100021, Peoples R China
Recommended Citation
GB/T 7714
An, Shu-Chang,Xu, Li-Li,Li, Feng-Di,et al. Triple combinations of neuraminidase inhibitors, statins and fibrates benefit the survival of patients with lethal avian influenza pandemic[J]. MEDICAL HYPOTHESES,2011,77(6):1054-1057.
APA An, Shu-Chang,Xu, Li-Li,Li, Feng-Di,Bao, Lin-Lin,Qin, Chuan,&Gao, Zhan-Cheng.(2011).Triple combinations of neuraminidase inhibitors, statins and fibrates benefit the survival of patients with lethal avian influenza pandemic.MEDICAL HYPOTHESES,77(6),1054-1057.
MLA An, Shu-Chang,et al."Triple combinations of neuraminidase inhibitors, statins and fibrates benefit the survival of patients with lethal avian influenza pandemic".MEDICAL HYPOTHESES 77.6(2011):1054-1057.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[An, Shu-Chang]'s Articles
[Xu, Li-Li]'s Articles
[Li, Feng-Di]'s Articles
百度学术
百度学术Similar articles in
[An, Shu-Chang]'s Articles
[Xu, Li-Li]'s Articles
[Li, Feng-Di]'s Articles
必应学术
必应学术Similar articles in
[An, Shu-Chang]'s Articles
[Xu, Li-Li]'s Articles
[Li, Feng-Di]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.